A prospective, randomised controlled multi-centre trial comparing in-hospital treatment and early assisted discharge for exacerbations of Chronic Obstructive Pulmonary Disease (COPD).

niversity Maastricht (UM), CAPHRI instituteiMTA, Erasmus MC Rotterdam0 sites235 target enrollmentTBD

ConditionsChronic Obstructive Pulmonary Disease (COPD), exacerbation treatment, early assisted discharge, cost-effectiveness. patient preference.

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Chronic Obstructive Pulmonary Disease (COPD), exacerbation treatment, early assisted discharge, cost-effectiveness. patient preference.
Sponsor: niversity Maastricht (UM), CAPHRI instituteiMTA, Erasmus MC Rotterdam
Enrollment: 235
Status: Recruiting
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

Registry

who.int

Start Date

TBD

End Date

TBD

Last Updated

2 years ago

Study Type

Interventional

Investigators

Sponsor

niversity Maastricht (UM), CAPHRI instituteiMTA, Erasmus MC Rotterdam

Eligibility Criteria

Inclusion Criteria

•1\. Age 40 and older;
•2\. Competent;

Exclusion Criteria

•1\. Major uncontrolled co\-morbidity;
•2\. Mental disability;

Outcomes

Primary Outcomes

Not specified

Similar Trials

Terminated

Phase 4

Clinical Performance and Safety Investigation of ENDOmetrial Washing MEdical DEvice ForielleInfertility

NCT03387059Merck KGaA, Darmstadt, Germany9

Active, not recruiting

Not Applicable

se of the corifolitropina alfa in oocyte donorsThe study is proposed to determine the level of compliance and pharmacoeconomic impact of three protocols for controlled ovarian stimulation in women participating in oocyte donation programTherapeutic area: Body processes [G] - Reproductive physiologi cal processes [G08]

EUCTR2014-001743-20-ESIVI Madrid

Completed

Not Applicable

Mycophenolate sodium vs Everolimus or Ciclosporin with Allograft Nephropathy as Outcome.prospective, open, randomized multicenter

NL-OMON25640MECANO Steering group Chair: S.Surachno/F.Bemelman255

Recruiting

Not Applicable

A prospective, open-label, multicenter randomized phase-II trial to evaluate the efficacy and safety of a sequential regimen of obinutuzumab (Gazyvaro) followed by obinutuzumab and venetoclax, followed by either standard venetoclax maintenance or MRD guided venetoclax maintenance in first-line patients with CLL and unfit for FCR-like regimensChronic Lymphocytic Leukemia (CLL)

NL-OMON23205HOVON data center70

Active, not recruiting

Not Applicable

A prospective, randomised, multicenter clinical trial investigating the reduction of Calcineurin inhibitor toxicity by means of steroid free long-term immune suppression with Ciclosporin A and Mycophenolat mofetil in children and adolescents after kidney transplantation - Recaltox-1

EUCTR2007-001166-33-DEniversitaetsklinikum Erlangen-Nuernberg